Cadila Healthcare Ltd., incorporated in 1995, is a largecap company with a market cap of Rs 36296.79 crore. Cadila Healthcare Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 3098.00 Crore to Sales Value (94.60 % of Total Sales), Export Incentives which contributed Rs 85.00 Crore to Sales Value (2.59 % of Total Sales), Other Operating Revenue which contributed Rs 82.10 Crore to Sales Value (2.50 % of Total Sales) and Royalty Income which contributed Rs 9.40 Crore to Sales Value (0.28 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 2768.70 Crore, down -12.18 % from last quarter Sales of Rs 3152.70 Crore and up 29.64 % from last year same quarter Sales of Rs 2135.70 Crore Company has reported net profit after tax of Rs 449.20 Crore in latest quarter. The company’s top management includes Dr.Sharvil P Patel, Mr.Apurva S Diwanji, Mr.Ganesh N Nayak, Mr.Humayun R Dhanrajgir, Mr.Mukesh M Patel, Mr.Nitin R Desai, Mr.Pankaj R Patel, Ms.Dharmishta N Rawal. Company has Mukesh M Shah & Co. as its auditoRs As on 30-06-2018, the company has a total of 1,023,742,600 shares outstanding.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price